about
Specificity, cross-reactivity and function of antibodies elicited by Zika virus infectionLymph-node resident CD8α+ dendritic cells capture antigens from migratory malaria sporozoites and induce CD8+ T cell responsesFusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilitiesDevelopment of a multilocus microsatellite typing approach for discriminating strains of Leishmania (Viannia) speciesClinical and demographic stratification of test performance: a pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis.Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in miceAdjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8⁺ T cells specific for infectious pathogens.Polymerase chain reaction detection of Leishmania kDNA from the urine of Peruvian patients with cutaneous and mucocutaneous leishmaniasis.A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys.P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru.Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in miDevelopment of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking VaccinesDetection and species identification of Leishmania DNA from filter paper lesion impressions for patients with American cutaneous leishmaniasis.Leishmania OligoC-TesT as a simple, rapid, and standardized tool for molecular diagnosis of cutaneous leishmaniasis in Peru.A Prime/Boost PfCS14KM/MVA-sPfCSM Vaccination Protocol Generates Robust CD8+ T Cell and Antibody Responses to Plasmodium falciparum Circumsporozoite Protein and Protects Mice against Malaria.Development and Assessment of Transgenic Rodent Parasites for the Preclinical Evaluation of Malaria Vaccines.A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components.Diagnosis of Zika Virus Infection by Peptide Array and Enzyme-Linked Immunosorbent Assay.Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease TropismEndocytosis of flavivirus NS1 is required for NS1-mediated endothelial hyperpermeability and is abolished by a single N-glycosylation site mutationIncreased serum sialic acid is associated with morbidity and mortality in a murine model of dengue diseaseCyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses
P50
Q26252507-D6D4533D-0AE3-43B7-BEAF-96BABE60DE4CQ27321397-4B890376-E317-4138-9F6F-4C9376917066Q31152863-E8497A48-0263-4DF0-BC12-44A53FBF8805Q33479906-694466ED-10BC-4DF4-AF20-BC9801FB3BB1Q34024857-8D5EF908-3CF1-4F07-A817-F4F2D6992F9EQ34119885-428F6F8D-9EC9-4DCC-BEE1-50A0BD878E89Q34274515-4478070E-D155-4EEF-B90F-2695A69C3E98Q34396077-3E066376-9376-4AFE-9F73-18985BDABB89Q34707789-C49D3BE7-B666-4C72-B199-73C79428FBBEQ34889790-5C18E750-ED82-404C-840A-F31EC614387EQ35561160-636F7163-27DE-4F68-9081-58CB2731EBF3Q36024455-E7BA0433-0043-4BB0-81A6-CD0634EBA400Q36314360-C52AA24A-973D-4482-A555-B156CF10B5D3Q36646698-624C5722-09D0-49CA-9DBB-8A34D607793DQ37036065-9725EECE-EF65-46F4-8E32-22F9EE273CB1Q37611985-572F3953-BACB-4A70-A585-E43822CFCC5CQ38913244-516B1C2F-D193-4CB4-B226-1482CFDC5463Q38995395-6B6769CD-21A0-43A0-B45D-9B6D02F928C8Q40290590-94AACF36-603C-4705-8BBC-465708CE51EFQ40715688-0CEEB1BD-762D-4339-A6E9-16DBC4A25F67Q41596362-3FEBA588-6238-4151-8012-0B31DB8F176CQ41722577-45052895-5642-4110-B91D-855406F837BEQ44081256-55E7E251-64B6-4F07-A251-B7ADA71452FCQ51336497-33DC626B-557D-4D98-A296-0C2A237B66CBQ61795508-9DC8CFCB-13E3-450B-B5D9-9007214E7937Q66678806-023F6890-3FFD-47DB-830F-C3BEB91D3D14Q90129052-FFFAD7DD-78CC-4836-B787-5B47624FCE42Q91044587-9B1F0A80-0F09-4FF9-BC9F-F8D5A579063F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Diego A Espinosa
@ast
Diego A Espinosa
@en
Diego A Espinosa
@es
Diego A Espinosa
@nl
Diego A Espinosa
@sl
type
label
Diego A Espinosa
@ast
Diego A Espinosa
@en
Diego A Espinosa
@es
Diego A Espinosa
@nl
Diego A Espinosa
@sl
prefLabel
Diego A Espinosa
@ast
Diego A Espinosa
@en
Diego A Espinosa
@es
Diego A Espinosa
@nl
Diego A Espinosa
@sl
P106
P1153
20734251800
P21
P31
P496
0000-0002-4364-5031